Corrigendum to “The 99th percentile values of six cardiac troponin assays established for a reference population using strict selection criteria” [Clin. Chim. Acta 464 (2017) 1–5](S0009898116304508)(10.1016/j.cca.2016.11.004);The 99th percentile values of six cardiac troponin assays established for a reference population using strict selection criteria

Clinica Chimica Acta

Volumn 464, Issue , 2017, Pages 1-5

  Ko, Dae Hyun ^a   Jeong, Tae Dong ^b   Cho, Eun Jung ^c   Lim, Jinsook ^d   Ji, Misuk ^e   Lee, Kyunghoon ^f   Lee, Woochang ^c   Yun, Yeo Min ^e   Chun, Sail ^c   Song, Junghan ^f   Kwon, Kye Chul ^d   Min, Won Ki ^c  

^a Hallym University College of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Chungnam National University College of Medicine   (South Korea)

^e Konkuk University Hospital   (South Korea)

^f Seoul National University Bundang Hospital   (South Korea)

Author keywords

99th percentile; Reference population; South Korean; Troponin

Indexed keywords

TROPONIN;

ACCURACY; ADULT; AGE DISTRIBUTION; AGED; ANALYTICAL EQUIPMENT; ARTICLE; FEMALE; HUMAN; IMMUNOASSAY ANALYZER; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DETERMINATION; REFERENCE VALUE; SEX DIFFERENCE; SEX RATIO; SOUTH KOREAN; VERY ELDERLY; ANIMAL; BLOOD; BLOOD ANALYSIS; CARDIAC MUSCLE; METABOLISM; PATIENT SELECTION; STANDARDS; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PATIENT SELECTION; REFERENCE VALUES; TROPONIN; YOUNG ADULT;

EID: 84994583231     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2017.01.031     Document Type: Erratum

References (36)

1. [1] Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., E.S.C.A.A.H.A.W.H.F.T.F.f.t.U.D.o.M.I. Joint, Katus, H.A., Lindahl, B., Morrow, D.A., Clemmensen, P.M., Johanson, P., Hod, H., Underwood, R., Bax, J.J., Bonow, R.O., Pinto, F., Gibbons, R.J., Fox, K.A., Atar, D., Newby, L.K., Galvani, M., Hamm, C.W., Uretsky, B.F., Steg, P.G., Wijns, W., Bassand, J.P., Menasche, P., Ravkilde, J., Ohman, E.M., Antman, E.M., Wallentin, L.C., Armstrong, P.W., Simoons, M.L., Januzzi, J.L., Nieminen, M.S., Gheorghiade, M., Filippatos, G., Luepker, R.V., Fortmann, S.P., Rosamond, W.D., Levy, D., Wood, D., Smith, S.C., Hu, D., Lopez-Sendon, J.L., Robertson, R.M., Weaver, D., Tendera, M., Bove, A.A., Parkhomenko, A.N., Vasilieva, E.J., Mendis, S., Third universal definition of myocardial infarction. Circulation 126:16 (2012), 2020–2035.
2. [2] Apple, F.S., A new season for cardiac troponin assays: it's time to keep a scorecard. Clin. Chem. 55:7 (2009), 1303–1306.
3. [3] Saenger, A.K., Beyrau, R., Braun, S., Cooray, R., Dolci, A., Freidank, H., Giannitsis, E., Gustafson, S., Handy, B., Katus, H., Melanson, S.E., Panteghini, M., Venge, P., Zorn, M., Jarolim, P., Bruton, D., Jarausch, J., Jaffe, A.S., Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin. Chim. Acta 412:9–10 (2011), 748–754.
4. [4] Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A.S., Katus, H.A., Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 56:2 (2010), 254–261.
5. [5] Apple, F.S., Ler, R., Murakami, M.M., Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin. Chem. 58:11 (2012), 1574–1581.
6. [6] Krintus, M., Kozinski, M., Boudry, P., Capell, N.E., Koller, U., Lackner, K., Lefevre, G., Lennartz, L., Lotz, J., Herranz, A.M., Nybo, M., Plebani, M., Sandberg, M.B., Schratzberger, W., Shih, J., Skadberg, O., Chargui, A.T., Zaninotto, M., Sypniewska, G., European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin. Chem. Lab. Med. 52:11 (2014), 1657–1665.
7. [7] Aw, T.C., Phua, S.K., Tan, S.P., Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender. Clin. Chim. Acta 422 (2013), 26–28.
8. [8] Koerbin, G., Tate, J., Potter, J.M., Cavanaugh, J., Glasgow, N., Hickman, P.E., Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin. Chem. Lab. Med. 50:5 (2012), 871–878.
9. [9] Ji, M., Moon, H.W., Hur, M., Yun, Y.M., Determination of high-sensitivity cardiac troponin I 99th percentile upper reference limits in a healthy Korean population. Clin. Biochem. 49:10–11 (2016), 756–761.
10. [10] Lippi, G., Dipalo, M., Avanzini, P., Formentini, A., Aloe, R., Analytical assessment of the Beckman Coulter Unicel DxI AccuTnI + 3 immunoassay. Diagnosis 1:2 (2014), 195–197.
11. [11] Venge, P., Johnston, N., Lindahl, B., James, S., Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J. Am. Coll. Cardiol. 54:13 (2009), 1165–1172.
12. [12] Kavsak, P.A., MacRae, A.R., Yerna, M.J., Jaffe, A.S., Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin. Chem. 55:3 (2009), 573–577.
13. [13] Keller, T., Ojeda, F., Zeller, T., Wild, P.S., Tzikas, S., Sinning, C.R., Peetz, D., Munzel, T., Blankenberg, S., Lackner, K.J., Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay. Int. J. Cardiol. 167:4 (2013), 1423–1429.
14. [14] McKie, P.M., Heublein, D.M., Scott, C.G., Gantzer, M.L., Mehta, R.A., Rodeheffer, R.J., Redfield, M.M., Burnett, J.C. Jr., Jaffe, A.S., Defining high-sensitivity cardiac troponin concentrations in the community. Clin. Chem. 59:7 (2013), 1099–1107.
15. [15] Collinson, P.O., Heung, Y.M., Gaze, D., Boa, F., Senior, R., Christenson, R., Apple, F.S., Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin. Chem. 58:1 (2012), 219–225.
16. [16] Sandoval, Y., Apple, F.S., The global need to define normality: the 99th percentile value of cardiac troponin. Clin. Chem. 60:3 (2014), 455–462.
17. [17] Apple, F.S., Jaffe, A.S., Collinson, P., Mockel, M., Ordonez-Llanos, J., Lindahl, B., Hollander, J., Plebani, M., Than, M., Chan, M.H., International Federation of Clinical Chemistry Task Force on Clinical Applications of Cardiac Bio-Markers, IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin. Biochem. 48:4–5 (2015), 201–203.
18. [18] Myers, G.L., Miller, W.G., Coresh, J., Fleming, J., Greenberg, N., Greene, T., Hostetter, T., Levey, A.S., Panteghini, M., Welch, M., Eckfeldt, J.H., National Kidney Disease Education Program Laboratory Working Group, Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin. Chem. 52:1 (2006), 5–18.
19. [19] Professional Practice Committee for the Standards of Medical Care in Diabetes-2016. Diabetes Care, 39(Suppl. 1), 2016, S107–S108.
20. [20] CLSI, Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures; Approved Guideline. Wayne, PA, 1999.
21. [21] CLSI, Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline. Third Edition, 2014 Wayne, PA.
22. [22] Sadler, W.A., Smith, M.H., A computer program for variance function estimation, with particular reference to immunoassay data. Comput. Biomed. Res. 20:1 (1987), 1–11.
23. [23] AccuTnI + 3 [Package Insert]. 2013, Beckman Coulter, Inc., Brea, CA.
24. [24] Dimension, L.O.C.I., Cardiac Troponin-I [Package Insert]. 2008, Siemens Healthcare Diagnostics Inc., Newark, DE.
25. [25] Dimension Vista Cardiac Troponin I [Package Insert]. 2008, Siemens Healthcare Diagnostics INC., Newark, DE.
26. [26] ADVIA, Centaur TnI-Ultra [Package Insert]. 2011, Siemens Healthcare Diagnostics Inc., Tarrytown, NY.
27. [27] ARCHITECT STAT High Sensitive Troponin-I [Package Insert]. 2013, Abbott Laboratories, Longford, Ireland.
28. [28] Troponin, T., hs [Package Insert]. 2013, Roche Diagnostics GmbH, Mannheim, Germany.
29. [29] Apple, F.S., Murakami, M.M., Serum 99th percentile reference cutoffs for seven cardiac troponin assays. Clin. Chem. 50:8 (2004), 1477–1479.
30. [30] Gaggin, H.K., Dang, P.V., Do, L.D., deFilippi, C.R., Christenson, R.H., Lewandrowski, E.L., Lewandrowski, K.B., Truong, B.Q., Pham, V.Q., Vu, V.H., Vu, T.V., Nguyen, T.B., Belcher, A.M., Femia, A., Kelley, C., Januzzi, J.L., Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: the North South East West Trial. Clin. Chem. 60:5 (2014), 758–764.
31. [31] Sthaneshwar, P., Jamaluddin, F.A., Fan, Y.S., Reference value for cardiac troponin I in a multi-ethnic group. Pathology 42:5 (2010), 454–456.
32. [32] CLSI, Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline. Second Edition, 2012 Wayne, PA.
33. [33] Tate, J.R., Bunk, D.M., Christenson, R.H., Barth, J.H., Katrukha, A., Noble, J.E., Schimmel, H., Wang, L., Panteghini, M., I.W.G.o.S.o.C.T. I, Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project. Clin. Chem. Lab. Med. 53:5 (2015), 677–690.
34. [34] Tate, J.R., Bunk, D.M., Christenson, R.H., Katrukha, A., Noble, J.E., Porter, R.A., Schimmel, H., Wang, L., Panteghini, M., I.W.G.o.S.o.T. I, Standardisation of cardiac troponin I measurement: past and present. Pathology 42:5 (2010), 402–408.
35. [35] Tate, J.R., Heathcote, D., Koerbin, G., Thean, G., Andriske, D., Bonar, J., Gill, J., The harmonization of cardiac troponin I measurement is independent of sample time collection but is dependent on the source of calibrator. Clin. Chim. Acta 324:1–2 (2002), 13–23.
36. [36] Wu, A.H., Christenson, R.H., Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care. Clin. Biochem. 46:12 (2013), 969–978.